We are proud to spotlight ATRI's Prof. Rema Raman, co-Principal Investigator of the Institute on Methods and Protocols for Advancement of Clinical Trials in Alzheimer’s and related dementias (IMPACT-AD) program. Prof. Raman is dedicated to accelerating progress in Alzheimer’s disease research through the development of the next generation of clinical trial leaders in Alzheimer’s disease and related dementias (ADRD).
Applications for the 2025 IMPACT-AD course are now open and due by April 30, 2025.
What is IMPACT-AD?
IMPACT-AD is a competitive, CME-accredited training program funded by the National Institute on Aging and the Alzheimer’s Association, designed to prepare investigators and professionals to lead the future of ADRD clinical trials.
About The Program:
Applicants must be based at a U.S. institution and may apply to only one track. Selected trainees will enroll in one of two in-person tracks.
Global Program:
Individuals with a primary appointment outside the U.S. may be eligible for the Global Program. To inquire, please send your CV/Biosketch and a Letter of Support to the IMPACT-AD Program Email with the subject line “IMPACT-AD 2025 Global Eligibility.” Please do not submit an application via ProposalCentral unless eligibility has been confirmed.
Learn More and Apply:
Visit the IMPACT-AD website for application templates, instructions, and course details. For questions or additional information, please contact the IMPACT-AD Program Team. We look forward to receiving your application!